Pathophysiologic implications of membrane phospholipid asymmetry in blood cells

Blood

Volumn 89, Issue 4, 1997, Pages 1121-1132

  Zwaal, Robert F A ^b   Schroit, Alan J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; PHOSPHOLIPID;

BLOOD CELL; COMPLEMENT ACTIVATION; HEMOSTASIS; HUMAN; HUMAN CELL; LIPID TRANSPORT; MEMBRANE STRUCTURE; MEMBRANE VESICLE; MOLECULAR RECOGNITION; PATHOPHYSIOLOGY; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; REVIEW; THROMBOSIS;

EID: 0031043059     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.4.1121     Document Type: Review

References (196)

1. Seigneuret M, Devaux PF: Asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: Relation to shape changes. Proc Natl Acad Sci USA 81:3751, 1984
2. Bevers EM, Comfurius P, VanRijn JLML, Hemker HC, Zwaal RFA: Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 122:429, 1982
3. Bevers EM, Comfurius P, Zwaal RFA: Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 736:57, 1983
4. Zwaal RFA, Comfurius P, VanDeenen LLM: Membrane asymmetry and blood coagulation. Nature 268:358, 1977
5. Zwaal RFA: Membrane and lipid involvement in blood coagulation. Biochim Biophys Acta 515:163, 1978
6. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM: Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207, 1992
7. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, VanSchie RCAA, Laface DM, Green DR: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182:1545, 1995
8. Bennett MR, Gibson DF, Schwartz SM, Tait JF: Binding and phagocytosis of apoptotic vascular smooth muscle cells is mediated in part by exposure of phosphatidylserine. Circ Res 77:1136, 1995
9. Casciola-Rosen L, Rosen A, Petri M, Schlissel M: Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosis. Proc Natl Acad Sci USA 93:1624, 1996
10. Connor J, Bucana C, Fidler IJ, Schroit AJ: Differentiation-dependent expression of phosphatidylserine in mammalian plasma membranes: Quantitative assessment of outer leaflet lipid by prothrombinase complex formation PS asymmetry. Proc Natl Acad Sci USA 86:3184, 1991
11. Utsugi T, Schroit AJ, Connor J. Bucana CD, Fidler IJ: Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 51:3062, 1991
12. Tanaka Y, Schroit AJ: Insertion of fluorescent phosphatidylserine into the plasma membrane of red blood cells: Recognition by autologous macrophages. J Biol Chem 258:11335, 1983
13. Schroit AJ, Madsen J, Tanaka Y:In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. J Biol Chem 260:5131, 1985
14. Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM: Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 149:4029, 1992
15. Fadok VA. Laszlo D, Noble PW, Weinslein L, Riches DWH, Henson PM: Particle digestibility is required for induction of the phosphatidylserine recognition mechanism used by murine macro-phages to phagocytose apoptotic cells. J Immunol 151:4274, 1993
16. Schroit AJ, Zwaal RFA: Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim Biophys Acta 1071:313, 1991
17. Devaux PF: Protein involvement in transmembrane lipid asymmetry. Annu Rev Biophys Biomol Struct 21:417, 1992
18. Devaux PF, Zachowski A: Maintenance and consequences of membrane phospholipid asymmetry. Chem Phys Lipids 73:107, 1994
19. Roelofsen B, OpdenKamp JAF: Plasma membrane phospholipid asymmetry and its maintenabce: The human erythrocyte as a model, in Hoekstra D (ed): Current Topics in Membranes, vol 40, New York, NY, Academic, 1994, p 7
20. Menon AK: Flippases. Trends Cell Biol 5:355, 1995
21. Diaz C, Schroit AJ: Role of translocates in the generation of phosphatidylserine asymmetry. J Membr Biol 151:1, 1996
22. Daleke DL, Huestis WH: Incorporation and translocation of aminophospholipids in human erythrocytes. Biochemisiry 24:5406, 1985
23. Connor J, Schroit AJ: Determination of lipid asymmetry in human red cells by resonance energy transfer. Biochemistry 26:5099, 1987
24. Morrot G, Herve P, Zachowski A, Fellmann P, Devaux PF: Aminophospholipid translocase of human erythrocytes: Phospholipid substrate specificity and effect of cholesterol. Biochemistry 28:3456, 1989
25. Connor J, Pak CH, Zwaal RFA, Schroit AJ: Bidirectional transbilayer movement of phospholipid analogs in human red blood cells. J Biol Chem 267:19412, 1992
26. Beleznay Z, Zachowski A, Devaux PF, Navazo MP, Ott P: ATP-dependent aminophospholipid translocation in erythrocyte vesicles - Stoichiometry of transport. Biochemistry 32:3146, 1994
27. Martin OC, Pagano RE: Transbilayer movement of fluorescent analogs of phosphatidylserine and phosphatidylethanolamine at the plasma membrane of cultured cells. J Biol Chem 262:5890, 1987
28. Connor J, Schroit AJ: Transbilayer movement of phosphatidylserine in erythrocytes. Inhibition of transport and preferential labeling of a 31,000 Dalton protein by sulfhydryl reactive reagents. Biochemistry 27:848, 1988
29. Connor J, Schroit AJ: Aminophospholipid translocation in erythrocytes: Evidence for the involvement of a specific transporter and an endofacial protein. Biochemistry 29:37, 1990
30. Bitbol M, Fellmann P, Zachowski A, Devaux PF: Ion regulation of phosphatidylserine and phosphatidylethanolamine outside-inside translocation in human erythrocytes. Biochim Biophys Acta 904:268, 1987
31. Tilly RHJ, Senden JMG, Comfurius P, Bevers EM, Zwaal RFA: Increased aminophospholipid translocase activity in human platelets during secretion. Biochim Biophys Acta 1029:188, 1990
32. 2+-ATPase: A candidate aminophospholipid translocase. FEBS Lett 266:29, 1990
33. Zimmerman ML, Daleke DL: Regulation of a candidate aminophospholipid-transporting ATPase by lipid. Biochemistry 32:12257, 1993
34. Auland ME, Morris MB, Roufogalis BD: Separation and characterization of two Mg(2+)-ATPase activities from the human erythrocyte membrane. Arch Biochem Biophys 312:272, 1994
35. Auiand ME, Roufogalis BD, Devaux PF, Zachowski A: Reconstitution of ATP-dependent aminophospholipid translocation in proteoliposomes. Proc Natl Acad Sci USA 91:10938, 1994
36. Zachowski A, Dolis D, Moreau C, Devaux PF: Reconstitution of an aminophospholipid translocase activity in proteoliposomes. Conférence Jacques Monod (CNRS) 'Lipid diversity in membranes and cellular functions', La Loads les Maures. France. 1995. p 80 (abstr)
37. Schroit AJ, Madsen J, Ruoho AE: Radioiodinaled, pbotoaffinity-labeted phosphatidylcholine and phosphatidylserine. Transfer properties and differential pholoreactive reaction with human erythrocyte membrane proteins. Biochemistry 26:1812, 1987
38. Connor J, Schroit AJ: Transbilayer movement of phosphatidylserine in non-human erythrocytes: Evidence that the aminophospholipid transporter is a ubiquitous membrane protein. Biochemistry 28:9680, 1989
39. Schroit AJ, Bloy C, Connor J, Cartron JP: Involvement of Rh blood group polypeptides in the maintenance of aminophospholipid asymmetry. Biochemistry 29:10303, 1990
40. Connor J, Schroit AJ: Transbilayer movement of phosphatidylserine in erythrocytes: Inhibitors of aminophospholipid transport block the association of photoiabeled lipid to its transporter. Biochim Biophys Acta 1066:37, 1991
41. Higgins CF: Flip-flop: The transmembrane translocation of lipids. Cell 79:393, 1994
42. Higgins CF: P-glycoprotein. To flip or not to flip? Curr Biol 4:259, 1994
43. Zachowski A, Henry JP, Devaux PF: Control of transmembrane lipid asymmetry in chromaffin granules by an ATP-dependent protein. Nature 340:75, 1989
44. Herrmann A, Zachowski A, Devaux PF: Protein-mediated phospholipid translocation in the endoplasmatic reticulum with a low lipid specificity. Biochemistry 29:2023, 1990
45. Sune A, Bette-Bobillo P, Bienvenue A, Fellmann P, Devaux PF: Selective outside-inside translocation of aminophospholipids in human platelets. Biochemistry 26:2972, 1987
46. Smeets EF, Comfurius P, Bevers EM, Zwaal RFA: Calcium-induced transbilayer scrambling of fluorescent phospholipid analogs in platelets and erythrocytes. Biochim Biophys Acta 1195:281, 1994
47. Zachowski A, Gaudry-Talarmain YM: Phospholipid transverse diffusion in synaptosomes: Evidence for the involvement of the aminophospholipid translocase. J Neuroehem 55:1352, 1990
48. Muller K, Labbe C, Zachowski A: Phospholipid transverse asymmetry in trout spermatozoa plasma membrane. Biochim Biophys Acta 1192:21, 1994
49. Muller K, Pomorski T, Muller P, Zachowski A, Herrmann A: Protein-dependent translocation of aminophospholipids and asymmetric transbilayer distribution of phospholipids in the plasma membrane of ram sperm cells. Biochemistry 33:9968, 1994
50. Pomorski T, Müller P, Zinimermann B, Burger K, Devaux PF, Herrmann A: Transbilayer movementof fluorescent and spin-labeled phospholipids in the plasma membrane of human fibroblasts: A quantitative approach, J Cell Sci 109:687, 1996
51. Julien M, Tournier JF. Tocanne JF: Basic fibroblast growth factor modulates the aminophospholipid translocase activity present in the plasma membrane of bovine aortic endothelial cells. Eur J Biochem 230:287, 1995
52. Hanada K, Pagano RE: A Chinese hamster ovary cell mutant defective in the non-enclocytic uptake of fluorescent analogs of phosphatidylserine: Isolation using a cytosol acidification protocol. J Cell Biol 128:793, 1995
53. Bitbol M, Devaux PF: Measurement of outward translocation of phospholipids across human erythrocyte membrane. Proc Nat Acad Sci USA 85:6783, 1988
54. Connor J, Gillum K, Schroit AJ: Maintenance of lipid asymmetry in red blood ceils and ghosts. Effect of divalent cations and serum albumin on the transbilayer distribution of phosphatidylserine. Biochim Biophys Acta 1025:82, 1990
55. Andrick C, Broring K, Deuticke B, Haest CWM: Fast translocation of phosphatidylcholine to the outer membrane leaflet after its synthesis at the inner membrane surface in human erythrocytes. Biochim Biophys Acta 1064:235, 1991
56. Sugihara T, Sugihara K, Hebbel RP: Phospholipid asymmetry during erythrocyte deformation: Maintenance of the unit membrane. Biochim Biophys Acta 1103:303, 1992
57. Comfurius P, Senden JM, Tilly RH, Schroit AJ, Bevers EM, Zwaal RFA: Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys Acta 1026:153, 1990
58. Devaux PF: Static and dynamic lipid asymmetry in cell membranes. Biochemistry 30:1163, 1991
59. Lucy JA: Loss of phospholipid asymmetry in cell fusion. Biochem Soc Trans 21:280, 1993
60. Farge E: Increased vesicle endocytosis due to an increase in the plasma membrane phosphatidylserine concentration. Biophys J 69:2501, 1995
61. Zwaal RFA, Comfurius P, Bevers EM: Mechanism and function of changes in membrane-phospholipid asymmetry in platelets and erythrocytes. Biochem Soc Trans 21:248, 1993
62. Rosing J, Bevers EM, Comfurius P, Hemker HC, VanDieijen G, Weiss HJ, Zwaal RFA: Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder. Blood 65:1557, 1985
63. Weiss HJ: Scott syndrome: A disorder of platelet coagulant activity. Semin Hematol 31:312, 1994
64. Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM: Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 87:1409, 1996
65. Williamson P, Bevers EM, Smeets EF, Comfurius P, Schlegel RA, Zwaal RFA: Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry 34:10448, 1995
66. 2+ induces transbilayer redistribution of all major phospholipids in human erythrocytes. Biochemistry 31:6355, 1992
67. 2+-induced phospholipid redistribution in the human erythrocyte membrane. J Biol Chem 269:6347, 1994
68. Martin DW, Jesty J: Calcium stimulation of procoagulant activity in human erythrocytes. ATP dependence and the effects of modifiers of stimulation and recovery. J Biol Chem 270:10468, 1995
69. Comfurius P, Williamson P, Smeets EF, Schlegel RA, Bevers EM, Zwaal RFA: Reconstitution of phospholipid scramblase activity from human blood platelets. Biochemistry 35:7631, 1996
70. 2+-dependent transbilayer movement of phospholipid. J Biol Chem 271:17205, 1996
71. 2+-induced loss of phospholipid asymmetry in the human erythrocyte: A study in Scott syndrome, a disorder of calcium-induced phospholipid scrambling. Blood 86:1983, 1995
72. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ: Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: An isolated detect in platelet procoagulant activity. J Biol Chem 264:17049, 1989
73. Wiedmer T, Shattil SJ, Cunningham M, Sims PJ: Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 29:623, 1990
74. Zwaal RFA, Comfurius P, Bevers EM: Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis. Biochim Biophys Acta 1180:1, 1992
75. Dachary-Prigent J, Freyssinet JM, Pasquet JM, Carron JC, Nurden AT: Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: A flow cytometry study showing a role for free sulfhydryl groups. Blood 81:2554, 1993
76. Fox JEB, Austin CD, Reynolds C, Steffen PK: Evidence that agonist-induced activation of calpain causes the shedding of procoaguiant-containing microvesicies from the membrane of aggregating platelets. J Biol Chem 266:13289, 1991
77. 2+-AT-Pase inhibitors. Biochemistry 34:11625, 1995
78. Geldwerth D, Kuypers FA, Butikofer P, Allary M, Lubin BH, Dcvaux PF: Transbilayer mobility and distribution of red cell phospholipids during storage. J Clin Invest 93:92, 1993
79. Tait JF, Gibson D: Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding. J Lab Clin Med 123:741, 1994
80. Sestier C, Sabolovic D, Geldwerth D, Moumaris M, Roger J, Pons JN, Halbreich A: Use of annexin V-ferrofluid to enumerate erythrocytes damaged in various pathologies or during storage in vitro. CR Acad Sci III 318:1141, 1995
81. Chiu D, Lubin B, Shohet SB: Erythrocyte membrane lipid reorganization during the sickling process. Br J Haematol 41:223, 1979
82. Chiu D, Lubin B, Roelofsen B, VanDeenen LLM: Sickled erythrocytes accelerate clotting in vitro: An effect of abnormal membrane lipid asymmetry. Blood 58:398, 1981
83. Kuypers FA, Lewis RA, Hua M, Schott MA, Discher D, Ernst JD, Lubin BH: Detection of altered membrane phospholipid asymmetry in subpopulations of human red blood cells using fluorescently-labeled annexin V. Blood 87:1179, 1996
84. Liu SC, Yi SJ, Mehta JR, Nichols PE, Ballas SK, Yacono PW, Golan DE, Palek J: Red cell membrane remodeling in sickle cell anemia. Sequestration of membrane lipids and proteins in Heinz bodies. J Clin Invest 97:29, 1996
85. Wali RK, Jaffe S, Kumar D, Kalra VK: Alterations in organization of phospholipids in erythrocytes as factor in adherence to endothelial cells in diabetes mellitus. Diabetes 37:104, 1988
86. Wilson MJ, Richterlowney K, Daleke DL: Hyperglycemia induces a loss of phospholipid asymmetry in human erythrocytes. Biochemistry 32:11302, 1993
87. Connor J, Pak CC, Schroit AJ: Exposure of phosphatidylserine in the outer leaflet of human red blood cells: Relationship to cell density, cell age, and clearance by mononuclear cells. J Biol Chem 269:2399, 1994
88. Diaz C, Morkowski J, Schroit AJ: Generation of phenotypically aged phosphatidylserine-expressing erythrocytes by dilauroyl-phosphatidylcholine-induced vesiculation. Blood 87:2956, 1996
89. Haest CWM, Plasa G, Kamp D, Deuticke B: Spectrin as a stabilizer of the phospholipid asymmetry in the human erythrocyte membrane. Biochim Biophys Acta 509:21, 1978
90. Haest CWM: Interactions between membrane skeleton proteins and the intrinsic domain of the erythrocyte membrane. Biochim Biophys Acta 694:331, 1982
91. Franck PFH, Bevers EM, Lubin BH, Comfurius P, Chiu DT-Y, OpDenKamp JAF, Zwaal RFA, VanDeenen LLM, Roelofsen B: Uncoupling of the membrane skeleton from the lipid bilayer: The cause of accelerated phospholipid flip-flop leading to enhanced procoagulant activity of sickled cells. J Clin Invest 75:183, 1985
92. Calvez J-Y, Zachowski A, Herrmann A, Morrot G, Devaux PF: Asymmetric distribution of phospholipids in spectrin-poor erythrocyte vesicles. Biochemistry 27:5666, 1988
93. Bruckheimer EB, Gillum KD, Schroit AJ: Co-localization of Rh polypeptides and the aminophospholipid transporter in dilauroyl-phosphatidylcholine-induced erythrocyte vesicles. Biochim Biophys Acta 1235:147, 1995
94. Kuypers FA, Lubin BH, Yee M, Agre P, Devaux PF, Geldwerth D: The distribution of erythrocyte phospholipids in hereditary spherocytosis demonstrates a minimal role for erythrocyte spectrin on phospholipid diffusion and asymmetry. Blood 81:1051, 1993
95. Smit JJM, Schinkel AH, Oude Elferink RPJ, Groen AK, Wagenaar E, VanDeemter L, Mol CAAM, Ottenhoff R, VanDerLugt NM, VanRoon MA, VanDerValk MA, Offerhaus GJA, Berns AJM, Borst P: Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75:451, 1993
96. Oude Elferink RPJ, Groen AK: The role of mdr2 P-glycoprotein in biliary lipid secretion. Cross-talk between cancer research and biliary physiology. J Hepatol 23:617, 1995
97. Higgins CF, Gottesman MM: Is the multidrug transporter a flippase? Trends Biochem Sci 17:18, 1992
98. Homolya L, Hollo Z, Germann UA, Pastan I, Gottesman MM, Sarkadi B: Fluorescent cellular indicators are extruded by the multidrug resistance protein. J Biol Chem 268:21493, 1993
99. Basse F, Gaffet P, Rendu F, Bienvenue A: Translocation of spin-labeled phospholipids through plasma membrane during thrombin-induced and ionophore-A23187-induced platelet activation. Biochemistry 32:2337, 1993
100. Gaffet P, Bettache N, Bienvenue A: Transverse redistribution of phospholipids during human platelet activation: Evidence for a vectorial outflux specific to aminophospholipids. Biochemistry 34:6762, 1995
101. Chang CP, Zhao J, Wiedmer T, Sims PJ: Contribution of platelet microparticle formation and granule secretion to the transmembrane migration of phosphatidylserine. J Biol Chem 268:7171, 1993
102. 2+-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: A study of the red blood cells of Scott syndrome. Blood 79:380, 1992
103. Farge E, Devaux PF: Shape changes of giant liposomes induced by an asymmetric transmembrane distribution of phospholipids. Biophys J 61:347,1992
104. Nemerson Y: The tissue factor pathway of blood coagulation. Semin Hematol 29:170, 1992
105. Esmon CT: Cell mediated events that control blood coagulation and vascular injury. Annu Rev Cell Biol 9:1, 1993
106. Kalafatis M, Swords NA, Rand MD, Mann KG: Membrane-dependent reactions in blood coagulation: Role of the vitamin K-dependent enzyme complexes. Biochim Biophys Acta 1227:113, 1994
107. Andree HAM, Nemerson Y: Tissue factor: Regulation of activity by flow and phospholipid surfaces. Blood Coagul Fibrinol 6:189, 1995
108. Bach R, Gentry R, Nemerson Y: Factor VII binding to tissue factor in reconstituted phospholipid vesicles: Induction of cooperativity by phosphatidylserine. Biochemistry 25:4007, 1986
109. Bach R, Rifkin DB: Expression of tissue factor procoagulant activity: Regulation by cytosolic calcium. Proc Natl Acad Sci USA 87:6995, 1990
110. Ruf W, Rehemtulla A, Morrissey JH, Edgington TS: Phospholipid-independent and dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem 266:2158, 1991
111. Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S: Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 76:1, 1990
112. Rosing J, Speijer H, Zwaal RFA: Prothrombin activation on phospholipid membranes with positive electrostatic potential. Biochemistry 27:8, 1988
113. Gilbert GE, Drinkwater D: Specific membrane binding of factor VIII is mediated by O-phospho-L-serine, a moiety of phosphatidylserine. Biochemistry 32:9577, 1993
114. Comfurius P, Smeets EF, Willems GM, Bevers EM, Zwaal RFA: Assembly of the prothrombinase complex on lipid vesicles depends on the stereochemical configuration of the polar headgroup of phosphatidylserine. Biochemistry 33:10319, 1994
115. Tans G, Rosing J, Thomassen MCLGD, Heeb MJ, Zwaal RFA, Griffin JH: Comparison of anticoagulant and procoagulant properties of stimulated platelets and platelet-derived microparticles. Blood 77:2641. 1991
116. Bevers EM, Comfurius P, Zwaal RFA: The nature of the binding site for prothrombinase at the platelet surface as revealed by lipolytic enzymes. Eur J Biochem 122:81, 1982
117. Thiagarajan P, Tait JF: Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem 265:17420, 1990
118. Rao LV, Tait JF, Hoang AD: Binding of annexin V to a human ovarian carcinoma cell line (OC-2008). Contrasting effects on cell surface factor VIIa/tissue factor activity and prothrombinase activity. Thromb Res 67:517, 1992
119. Rosing J, VanRijn JLML, Bevers EM, VanDieijen G, Comfurius P, Zwaal RFA: The role of activated human platelets in prothrombin and factor X activation. Blood 65:319, 1985
120. Zwaal RFA, Bevers EM, Comfurius P, Rosing J, Tilly RHJ, Verhallen PFJ: Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells: Mechanism and physiological significance. Mol Cell Biochem 91:23, 1989
121. Sims PJ, Faioni EM, Wiedmer T, Shattil SJ: Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 263:18205, 1988
122. Holme PA, Solum NO, Brosstad F, Roger M, Abdelnoor M: Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and Western blotting. Thromb Haemost 72:666, 1994
123. Lee Y, Jy W, Horstman LL, Janania J , Kelley R, Ahn YS: Elevated platelet microparticles in multiinfarct dementias and transient ischemic attacks. Thromb Res 72:295, 1993
124. Jy W, Horstman LL, Wang F, Duncan R, Ahn YS: Platelet factor 3 in plasma fractions: Its relation to microparticle size and thromboses. Thromb Res 80:471, 1995
125. Jy W, Mao WW, Horstman LL, Tao J, Ahn YS: Platelet microparticles bind, activate and aggregate neutrophils in vitro. Blood Cells Mol Dis 21:217, 1995
126. Malhotra R, Taylor NR, Bird MI: Anionic phospholipids bind to L-selectin (but not E-selectin) at a site distinct from the carbohydrate-binding site. Biochem J 314:297, 1996
127. Bona R, Lee E, Rickles F: Tissue factor apoprotein: Intracellular transport and expression in shed membrane vesicles. Thromb Res 48:487, 1987
128. Dvorak HF, Van DeWater L, Bitzer AM, Dvorak AM, Anderson D, Harvey VS, Bach R, Davis GL, DeWolf W, Carvalho AC: Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 43:4434, 1983
129. Weiss HJ, Vivic WJ, Lages BA, Rogers J: Isolated deficiency of platelet procoagulant activity. Am J Med 67:206, 1979
130. Miletich JP, Katie WH, Hofmann SL, Stanford N, Majerus PW: Deficiency of factor Xa-factor Va binding sites on the platelets of a patient with a bleeding disorder. Blood 54:1015, 1979
131. Ahmad SS, Rawala-Sheikh R, Ashby B, Walsh PN: Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott Syndrome. J Clin Invest 84:824, 1989
132. Kojima H, Newton-Nash D, Weiss HJ, Zhao J, Sims PJ, Wiedmer T: Production and characterization of transformed B-lymphocytes expressing the membrane defect of Scott syndrome. J Clin Invest 94:2237, 1994
133. Chandra R, Joshi PC, Bajpaj VK, Gupta CM: Membrane phospholipid organization in calcium-loaded human erythrocytes. Biochim Biophys Acta 902:253, 1987
134. Lupu C, CaIb M, Ionescu M, Lupu F: Enhanced, prothrombin and intrinsic factor X activation on blood platelets from diabetic patients. Thromb Haemost 70:579, 1993
135. Epand RM, Stafford A, Leon B, Lock PE, Tytler EM, Segrest JP, Anantharamaiah OM: HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity. Arterioscler Thromb 14:1775, 1994
136. Tracy PB, Eide LL, Mann KG: Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. J Biol Chem 260:2119, 1985
137. Tracy PB: Regulation of thrombin generation at cell surfaces. Semin Thromb Haemost 14:227, 1988
138. Robinson RA, Worfolk L, Tracy PB: Endotoxin enhances the expression of monocyte prothrombinase activity. Blood 79:406, 1992
139. Satta N, Toti F, Feugeas O, Bohbot A, Dachary-Prigent J, Eschwège V, Hedman H, Freyssinet JM: Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharides. J Immunol 153:3245, 1994
140. Gregory SA, Morrissey JH, Edgington TS: Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 9:2752, 1989
141. Rapaport SI, Rao LVM: Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 12:1111, 1992
142. Hamilton KK, Hattori R, Esmon CT, Sims PJ: Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 265:3809, 1990
143. VanDeMeer BW, Fugate RD, Sims PJ: Complement proteins C5b-9 induce transbilayer migration of membrane phospholipids. Biophys J 56:935, 1989
144. Fattal E, Nir S, Parente RA, Szoka FC: Pore-forming peptides induce rapid phospholipid flip-flop in membranes. Biochemistry 33:6721, 1994
145. Aimers W: Exocytosis. Annu Rev Physiol 52:607, 1990
146. Andoh K, Kubota T, Takada M, Tanaka H, Kobayashi N, Maekawa T: Tissue factor activity in leukemia cells. Special reference to disseminated intravascular coagulation. Cancer 59:748, 1987
147. Bauer KA, Conway EM, Bach R, Konigsberg WH, Griffin JD, Demetri G: Tissue factor gene expression in acute myeloblastic leukemia. Thromb Res 56:425, 1989
148. Tallman MS, Kwaan HC: Reassessing the hemostatic disorder associated with acute promyelocytic leukemia. Blood 79:543, 1992
149. Falanga A, Gordon SG: Isolation and characterization of cancer procoagulant: A cysteine proteinase from malignant tissue. Biochemistry 24:5558, 1985
150. Donati MB, Gambacorti-Passerini C, Casali B, Falanga A, Vannotti P, Fossati G, Semeraro N, Gordon SG: Cancer procoagulant in human tumor cells: Evidence from melanoma patients. Cancer Res 46:6471, 1986
151. Falanga A, lacoviello L, Evangelista V, Belotti D, Consonni R, D'Orazio A, Robba L, Donati MB, Barbui T: Loss of blast cell procoagulant activity and improvement of hemostatic variables in patients with acute promyelocytic leukemia administered all-trans-retinoic acid. Blood 86:1072, 1995
152. VanDeWater L, Tracy PB, Aronson D, Mann KG, Dvorak HF: Tumor cell generation of thrombin via functional prothrombinase assembly. Cancer Res 45:5521, 1985
153. Sugimura M, Donate R, Kakkar VV, Scully MF: Annexin V as a probe of the contribution of anionic phospholipids to the procoagulant activity of tumor cell surfaces. Blood Coagul Fibrinol 5:365, 1994
154. Bastida E, Ordinas A, Escolar G, Jamieson GA: Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. Blood 64:177, 1984
155. McNeil HP, Chesterman CN, Krilis SA: Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 49:193, 1991
156. Roubey RA: Autoantibodies to phospholipid-binding plasma proteins: A new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. Blood 84:2854, 1994
157. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA: Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87:4120, 1990
158. Galli M, Comfurius P, Maassen C, Hemker HC, DeBaets MH, VanBreda-Vriesman PJC, Barbui T, Zwaal RFA, Bevers EM: Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335:1544, 1990
159. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RFA: Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 66:629, 1991
160. Costing JD, Derksen RH, Bobbink IW, Hackeng TM, Bouma BN, DeGroot PG: Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: An explanation for their pathogenic mechanism? Blood 81:2618, 1993
161. Permpikul P, Rao LV, Rapaport SI: Functional and binding studies of the roles of prothrombin and β2-glycoprotein I in the expression of lupus anticoagulant activity. Blood 83:2878, 1994
162. Pengo V, Biasiolo A, Brocco T, Tonetto S, Ruffatti A: Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Thromb Haemost 75:721, 1996
163. Galli M, Bevers EM, Comfurius P, Barbui T, Zwaal RFA: Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles. Br J Haematol 83:466, 1993
164. Ciaudo M, Horellou MH, Audouin J, De Carbonnieres C, Conard J, Samama M: Lupus anticoagulant associated with primary malignant lymphoplasmacytic lymphoma of the spleen: A report of four patients. Am J Hematol 38:271, 1991
165. Fidler IJ, Schroit AJ: Recognition and destruction of neoplastic cells by activated macrophages. Discrimination of altered self. Biochim Biophys Acta 948:151, 1988
166. Pak CC, Fidler IJ: Molecular mechanisms for activated macrophage recognition of tumor cells. Semin Cancer Biol 2:189, 1991
167. Poste G, Bucana C, Raz A, Bugelski P, Kirsh R, Fidler IJ: Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res 42:1412, 1982
168. Raz A, Bucana C, Fogler WE, Poste G, Fidter IJ: Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages. Cancer Res 41:487, 1981
169. Schroit AJ, Fidler IJ: Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by muramyl dipeptide liposomes. Cancer Res 42:161, 1982
170. Lane A, O'Connell JL, Marlar RA: Erythrocyte membrane vesicles and irreversibly sickled cells bind protein. Am J Hematol 47:295, 1994
171. Borenstain-Ben Yashar V, Barenholz Y, Hy-Am E, Rachmilewitz EA, Eldor A: Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol 44:63, 1993
172. Blumenfeld N, Zachowski A, Galacteros F, Beuzard Y, Devaux PF: Transmembrane mobility of phospholipids in sickle erythrocytes: Effect of deoxygenation on diffusion and asymmetry. Blood 77:849, 1991
173. Muller P, Zachowski A, Beuzard Y, Devaux PF: Transmembrane mobility and distribution of phospholipids in the membrane of mouse beta-thalassaemic red blood cells. Biochim Biophys Acta 1151:7, 1993
174. Schwanz RS, Tanaka Y, Fidler U, Chiu D, Lubin B, Schroit AJ: Increased adherence of sickled and phosphatidylserine enriched human erythrocytes to cultured human peripheral blood monocytes. J Clin Invest 75:1965, 1985
175. Pak CC, Fidler IJ: Activated macrophages distinguish undifferentiated-tumorigenic from differentiated-nontumorigenic murine erythroleukemia cells. Differentiation 41:49, 1989
176. Bartosz G: Erythrocyte aging: Physical and chemical membrane changes. Gerontology 37:33, 1991
177. Piomelli S, Seaman C: Mechanism of red blood cell aging: Relationship of cell density and cell age. Am J Hematol 42:46, 1993
178. Herrmann A, Devaux PF: Alteration of the aminophospholipid translocase activity during in vivo and artificial aging of human erythrocytes. Biochim Biophys Acta 1027:41, 1990
179. Gaffet P, Basse F, Bienvenue A: Loss of phospholipid asymmetry in human platelet plasma membrane after 1-12 days of storage. An ESR study. Eur J Biochem 222:1033, 1994
180. Jain SK: The accumulation of malonyldialdehyde, a product of fatty acid peroxidation, can disturb aminophospholipid organization in the membrane bilayer of human erythrocytes. J Biol Chem 259:3391, 1984
181. Jain SK: In vivo externalization of phosphatidylserine and phosphatidylethanolamine in the membrane bilayer and hypercoagulability by the lipid peroxidation of erythrocytes in rats. J Clin Invest 76:281, 1985
182. Bevers EM, Tilly RH, Senden JM, Comfurius P, Zwaal RFA: Exposure of endogenous phosphatidylserine at the outer surface of stimulated platelets is reversed by restoration of aminophospholipid translocase activity. Biochemistry 28:2382, 1989
183. Jain SK: Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocyles. Biochim Biophys Acta 937:205, 1988
184. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RMJ, Pals ST, VanOers MHJ: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415, 1994
185. Verhoven B, Schlegel RA, Williamson P: Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal on apoptotic T lymphocytes. J Exp Med 182:1597, 1995
186. Mower DA, Peckham DW, Illera VA, Fishbaugh JK, Stunz LL, Ashman RF: Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis. J Immunol 152:4832, 1994
187. Ashman RF, Peckham D, Alhasan S, Stunz LL: Membrane unpacking and rapid disposal of apoptotic cells. Immunol Lett 48:159, 1995
188. Squier MK, Miller AC, Malkinson AM, Cohen JJ: Calpain activation in apoptosis. J Cell Physiol 159:229, 1994
189. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D: The 94-to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci USA 92:9580, 1995
190. Ottnad E, Parthasarathy S, Sambrano GR, Ramprasad MP, Quehenberger O, Kondratenko N, Green S, Steinberg D: A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: Partial purification and role in recognition of oxidatively damaged cells. Proc Natl Acad Sci USA 92:1391, 1995
191. Sambrano GR, Steinberg D: Recognition of oxidatively damaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: Role of membrane phosphatidylserine. Proc Natl Acad Sci USA 92:1396, 1995
192. Rigotti A, Acton SL, Krieger M: The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J Biol Chem 270:16221, 1995
193. Ren Y, Silverstein RL, Alien J, Savill J: CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 181:1857, 1995
194. Fukasawa M, Adachi H, Hirota K, Tsujimoto M, Arai H, Inoue K: SRBl, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells. Exp Cell Res 222:246, 1996
195. Chonn A, Semple SC, Cullis PR: Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of "non-self" particles. J Biol Chem 270:25845, 1995
196. Savill J, Fadok V, Henson P, Haslett C: Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14:131, 1993